November 9, 2018
Forge Therapeutics CEO Zak Zimmerman stands in the company’s lab. Forge and other San Diego biotechs are taking on life-threatening infections called superbugs.
Stories this photo appears in:
HEALTH: Region Has Talent, Grants, And Track Record for Fight
In a race to combat antibiotic resistance, big pharma bailed. Investors are skeptical. But Forge Therapeutics isn’t deterred.